ArticleRheumatology (Oxford, England)2026

Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathies.

Nathan Barreth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.